Tonix Pharmaceuticals Holding Corp. (TNXP) earnings date, results and what the price requires
Nasdaq · SEC CIK 0001430306 · SEC filings checked Oct 17, 2026
Next report
Not yet known
Fewer than three past results filings to estimate from.
Last close
$6.42
Polygon.io daily close, Oct 15, 2026. End of day, not live.
Trailing diluted EPS
$-13.24
Sum of quarters ending Jun 30, 2026, Mar 31, 2026, Dec 31, 2025, Sep 30, 2025
Previous results (SEC filings)
| Quarter ended | Reported | Revenue | Net income | Diluted EPS | Source |
|---|---|---|---|---|---|
| Sep 30, 2026 | Oct 15, 2026 | Announced; figures arrive with the 10-Q | — | — | Filing |
| Jun 30, 2026 | Aug 10, 2026 | $13.5M | $-40.6M | $-2.44 | Filing |
| Mar 31, 2026 | May 1, 2026 | $6.9M | $-40.2M | $-2.93 | Filing |
| Dec 31, 2025 | Feb 3, 2026 | $5.4M | $-46.9M | $-4.28 | Filing |
| Sep 30, 2025 | Oct 27, 2025 | $3.3M | $-32.0M | $-3.59 | Filing |
| Jun 30, 2025 | Jul 25, 2025 | $2.0M | $-28.3M | $-3.86 | Filing |
| Mar 31, 2025 | Apr 25, 2025 | $2.4M | $-16.8M | $-2.84 | Filing |
| Dec 31, 2024 | Feb 3, 2025 | $2.6M | $-22.1M | $2302.65 | Filing |
| Sep 30, 2024 | Oct 28, 2024 | $2.8M | $-14.2M | $-22.68 | Filing |
What would Tonix Pharmaceuticals Holding Corp. have to report for its valuation to change?
Trailing earnings are negative, so a price-to-earnings reverse model does not apply. The model is not shown rather than filled with assumptions.
Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.